Sosei buys Idorsia Pharmaceuticals' Japan, Korea units for $466 million - Nikkei
20/07/2023 07:23
TOKYO, July 20 (Reuters) - Japanese biopharma Sosei
Group 4565.T has bought Swiss-based Idorsia Pharmaceuticals'
IDIA.S businesses in Japan and South Korea for about 65
billion yen ($466.08 million), the Nikkei newspaper reported on
Thursday.
Sosei, in its largest-ever acquisition deal, has also bought
some milestone rights to develop and sell drugs from Idorsia,
Nikkei said.
($1 = 139.4600 yen)
(Reporting by Kantaro Komiya; Editing by Kim Coghill)
((Kantaro.Komiya@thomsonreuters.com; Twitter: @kantarokomiya;))